View Older Stories View More Recent Stories

Mar 20, 2025 05:57PM Alnylam Pharma (ALNY) announces FDA approval of AMVUTTRA

Mar 20, 2025 03:40PM Alnylam Pharma (ALNY) Halted, News Pending

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 5, 2025 07:03AM Alnylam Pharma (ALNY) Announces Retirement of Longtime Board Member, Dr. Phillip A. Sharp, Company Co-Founder and Industry Luminary

Mar 3, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Feb 26, 2025 09:35AM RBC on Alnylam Pharmaceuticals (ALNY): 'We Would Be Buyers Ahead Of Upcoming PDUFA Date'

Feb 26, 2025 08:10AM Piper Sandler Reiterates Overweight on Alnylam Pharmaceuticals (ALNY), 'Confident in AMVUTTRA Approval'

Feb 25, 2025 06:45AM Alnylam Pharmaceuticals (ALNY) PT Raised to $500 at H.C. Wainwright

Feb 18, 2025 06:50AM Alnylam Pharmaceuticals (ALNY) PT Raised to $385 at Canaccord Genuity

Feb 13, 2025 08:03AM Alnylam Pharma (ALNY) Tops Q4 EPS by 64c ; Offers Guidance

Feb 11, 2025 08:18AM RBC Capital on Alnylam Pharmaceuticals (ALNY): 'Our Expert Sees A Favorable Set-up'

Feb 3, 2025 05:11AM Goldman Makes Monthly Adjustment to Director's Cut Conviction List

Jan 14, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Jan 13, 2025 12:21PM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY) After a Solid TTR Beat

Jan 13, 2025 11:20AM Alnylam Pharma (ALNY) Announces Preliminary Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance

Dec 22, 2024 04:00AM Barclays shares outlook for Biotech in 2025, names preferred stocks

Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?

Nov 26, 2024 06:52AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Nov 25, 2024 08:23AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)

Nov 25, 2024 07:01AM Alnylam Pharma (ALNY) Announces U.S. FDA Acceptance of sNDA for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Nov 19, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Nov 18, 2024 08:56AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Nov 12, 2024 04:54AM Wolfe Research Downgrades Alnylam Pharmaceuticals (ALNY) to Underperform

Nov 4, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Oct 31, 2024 08:05AM Alnylam Pharma (ALNY) Tops Q3 EPS by 43c, Misses on Revenue; Offers FY24 Guidance

Oct 24, 2024 06:23AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Oct 21, 2024 08:21AM Alnylam Pharmaceuticals (ALNY) PT Raised to $371 at TD Cowen

Oct 18, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Oct 16, 2024 08:04AM Alnylam Pharma (ALNY) Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Oct 11, 2024 06:20AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Oct 10, 2024 08:21AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Oct 10, 2024 07:56AM BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)

Oct 10, 2024 07:43AM Piper Sandler Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)

Oct 10, 2024 06:25AM Oppenheimer Reiterates Perform Rating on Alnylam Pharmaceuticals (ALNY)

Oct 10, 2024 05:50AM Citi Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Oct 10, 2024 05:36AM Goldman Sachs Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Oct 10, 2024 05:30AM BofA Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Oct 9, 2024 07:03AM Alnylam Pharma (ALNY) Submits sNDA to FDA for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy

Oct 1, 2024 06:49AM Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Sep 30, 2024 08:35AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Sep 30, 2024 07:52AM Piper Sandler Reiterates Overweight Rating on Alnylam Pharmaceuticals (ALNY)

Sep 30, 2024 05:42AM Goldman Sachs Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Sep 27, 2024 06:01AM BofA Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Sep 16, 2024 08:41AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Sep 4, 2024 05:22AM Alnylam Pharmaceuticals (ALNY) PT Raised to $307 at BofA Securities

Sep 3, 2024 08:05AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Sep 3, 2024 07:37AM Oppenheimer Reiterates Perform Rating on Alnylam Pharmaceuticals (ALNY)

Sep 3, 2024 07:29AM Wolfe Research Reiterates Peerperform Rating on Alnylam Pharmaceuticals (ALNY)

Sep 3, 2024 07:24AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Sep 3, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

View More Recent Stories View Older Stories